Pilot study of high dose ICE (ifosfamide, carboplatin, etoposide) chemotherapy and autologous bone marrow transplant (ABMT) with neoR-transduced bone marrow and peripheral blood stem cells in patients with metastatic breast cancer.
O'Shaughnessy
J A
JA
Cowan
K H
KH
Wilson
W
W
Bryant
G
G
Goldspiel
B
B
Gress
R
R
Nienhuis
A W
AW
Dunbar
C
C
Sorrentino
B
B
Stewart
F M
FM
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D002945:Cisplatin / Q000008:administration & dosage; D002985:Clinical Protocols; D003131:Combined Modality Therapy; D004351:Drug Resistance / Q000235:genetics; D005047:Etoposide / Q000008:administration & dosage; D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D009355:Neomycin / Q000494:pharmacology; D010865:Pilot Projects; D012190:Retroviridae / Q000235:genetics; D033581:Stem Cell Transplantation; D014161:Transduction, Genetic; D014182:Transplantation, Autologous
D005047:Etoposide; D009355:Neomycin; D002945:Cisplatin; D007069:Ifosfamide